In this posthoc analysis , patients with early RA who received MTX monotherapy or ADA + MTX in the PREMIER study were categorized based on clinical responses at @ and @ months -LSB- American College of Rheumatology response , @-joint Disease Activity Score ( DAS@ ) - C-reactive protein ( CRP ) improvement and targets -RSB- .